MRI appearance of myocutaneous flaps commonly used in orthopedic reconstructive surgery

Michael Fox, Laura W. Bancroft, Jeffrey J. Peterson, Mark J. Kransdorf, Sarvam P. TerKonda, Mary I. O'Connor

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

OBJECTIVE. Our aim was to describe the MRI appearance of myocutaneous flaps and to determine whether postoperative radiation therapy affects imaging. MATERIALS AND METHODS. We retrospectively reviewed 30 myocutaneous flaps in 27 patients (n = 165 examinations; mean, 6.1 examinations per patient). Examinations were analyzed for flap type, location, degree of atrophy, signal intensity, and enhancement. RESULTS. Sixty-three percent (19/30) of the flaps developed high T1-weighted signal (mean, 15 months); 83% (25/30) developed high T2-weighted signal (mean, 10 months). This occurred sooner in those patients with postoperative radiation therapy (9 vs 12 months). T2-weighted signal returned to baseline in 32% (8/25) of the flaps (mean, 21 months); this occurred sooner in flaps not exposed to postoperative radiation (10 months vs 38 months). Seventy-one percent (20/28) of the flaps enhanced greater than the background musculature. Enhancement was seen more frequently in patients treated with postoperative radiation therapy than those not treated with radiation (83% vs 63%). All flaps atrophied; however, the two functional latissimus dorsi flaps atrophied less. Although increased T2-weighted signal and enhancement were seen in flaps after postoperative radiation therapy as compared with those without, this was not significant (p = 0.35 and p = 0.40, respectively). CONCLUSION. Myocutaneous flaps used in orthopedic reconstructive surgery typically show increased signal intensity on T2-weighted images and contrast enhancement initially, followed by some degree of atrophy and increased signal intensity on T1-weighted images. Postoperative radiation therapy may increase the likelihood that the flap will exhibit increased T2-weighted signal and enhancement.

Original languageEnglish (US)
Pages (from-to)800-806
Number of pages7
JournalAmerican Journal of Roentgenology
Volume187
Issue number3
DOIs
StatePublished - Sep 2006

Fingerprint

Reconstructive Surgical Procedures
Myocutaneous Flap
Orthopedics
Radiotherapy
Atrophy
Radiation
Image Enhancement
Superficial Back Muscles

Keywords

  • MRI
  • Musculoskeletal imaging
  • Myocutaneous flap
  • Orthopedic surgery
  • Radiation therapy

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Fox, M., Bancroft, L. W., Peterson, J. J., Kransdorf, M. J., TerKonda, S. P., & O'Connor, M. I. (2006). MRI appearance of myocutaneous flaps commonly used in orthopedic reconstructive surgery. American Journal of Roentgenology, 187(3), 800-806. https://doi.org/10.2214/AJR.05.0484

MRI appearance of myocutaneous flaps commonly used in orthopedic reconstructive surgery. / Fox, Michael; Bancroft, Laura W.; Peterson, Jeffrey J.; Kransdorf, Mark J.; TerKonda, Sarvam P.; O'Connor, Mary I.

In: American Journal of Roentgenology, Vol. 187, No. 3, 09.2006, p. 800-806.

Research output: Contribution to journalArticle

Fox, M, Bancroft, LW, Peterson, JJ, Kransdorf, MJ, TerKonda, SP & O'Connor, MI 2006, 'MRI appearance of myocutaneous flaps commonly used in orthopedic reconstructive surgery', American Journal of Roentgenology, vol. 187, no. 3, pp. 800-806. https://doi.org/10.2214/AJR.05.0484
Fox, Michael ; Bancroft, Laura W. ; Peterson, Jeffrey J. ; Kransdorf, Mark J. ; TerKonda, Sarvam P. ; O'Connor, Mary I. / MRI appearance of myocutaneous flaps commonly used in orthopedic reconstructive surgery. In: American Journal of Roentgenology. 2006 ; Vol. 187, No. 3. pp. 800-806.
@article{6f3f9853bb044463922b9538c8f314fd,
title = "MRI appearance of myocutaneous flaps commonly used in orthopedic reconstructive surgery",
abstract = "OBJECTIVE. Our aim was to describe the MRI appearance of myocutaneous flaps and to determine whether postoperative radiation therapy affects imaging. MATERIALS AND METHODS. We retrospectively reviewed 30 myocutaneous flaps in 27 patients (n = 165 examinations; mean, 6.1 examinations per patient). Examinations were analyzed for flap type, location, degree of atrophy, signal intensity, and enhancement. RESULTS. Sixty-three percent (19/30) of the flaps developed high T1-weighted signal (mean, 15 months); 83{\%} (25/30) developed high T2-weighted signal (mean, 10 months). This occurred sooner in those patients with postoperative radiation therapy (9 vs 12 months). T2-weighted signal returned to baseline in 32{\%} (8/25) of the flaps (mean, 21 months); this occurred sooner in flaps not exposed to postoperative radiation (10 months vs 38 months). Seventy-one percent (20/28) of the flaps enhanced greater than the background musculature. Enhancement was seen more frequently in patients treated with postoperative radiation therapy than those not treated with radiation (83{\%} vs 63{\%}). All flaps atrophied; however, the two functional latissimus dorsi flaps atrophied less. Although increased T2-weighted signal and enhancement were seen in flaps after postoperative radiation therapy as compared with those without, this was not significant (p = 0.35 and p = 0.40, respectively). CONCLUSION. Myocutaneous flaps used in orthopedic reconstructive surgery typically show increased signal intensity on T2-weighted images and contrast enhancement initially, followed by some degree of atrophy and increased signal intensity on T1-weighted images. Postoperative radiation therapy may increase the likelihood that the flap will exhibit increased T2-weighted signal and enhancement.",
keywords = "MRI, Musculoskeletal imaging, Myocutaneous flap, Orthopedic surgery, Radiation therapy",
author = "Michael Fox and Bancroft, {Laura W.} and Peterson, {Jeffrey J.} and Kransdorf, {Mark J.} and TerKonda, {Sarvam P.} and O'Connor, {Mary I.}",
year = "2006",
month = "9",
doi = "10.2214/AJR.05.0484",
language = "English (US)",
volume = "187",
pages = "800--806",
journal = "American Journal of Roentgenology",
issn = "0361-803X",
publisher = "American Roentgen Ray Society",
number = "3",

}

TY - JOUR

T1 - MRI appearance of myocutaneous flaps commonly used in orthopedic reconstructive surgery

AU - Fox, Michael

AU - Bancroft, Laura W.

AU - Peterson, Jeffrey J.

AU - Kransdorf, Mark J.

AU - TerKonda, Sarvam P.

AU - O'Connor, Mary I.

PY - 2006/9

Y1 - 2006/9

N2 - OBJECTIVE. Our aim was to describe the MRI appearance of myocutaneous flaps and to determine whether postoperative radiation therapy affects imaging. MATERIALS AND METHODS. We retrospectively reviewed 30 myocutaneous flaps in 27 patients (n = 165 examinations; mean, 6.1 examinations per patient). Examinations were analyzed for flap type, location, degree of atrophy, signal intensity, and enhancement. RESULTS. Sixty-three percent (19/30) of the flaps developed high T1-weighted signal (mean, 15 months); 83% (25/30) developed high T2-weighted signal (mean, 10 months). This occurred sooner in those patients with postoperative radiation therapy (9 vs 12 months). T2-weighted signal returned to baseline in 32% (8/25) of the flaps (mean, 21 months); this occurred sooner in flaps not exposed to postoperative radiation (10 months vs 38 months). Seventy-one percent (20/28) of the flaps enhanced greater than the background musculature. Enhancement was seen more frequently in patients treated with postoperative radiation therapy than those not treated with radiation (83% vs 63%). All flaps atrophied; however, the two functional latissimus dorsi flaps atrophied less. Although increased T2-weighted signal and enhancement were seen in flaps after postoperative radiation therapy as compared with those without, this was not significant (p = 0.35 and p = 0.40, respectively). CONCLUSION. Myocutaneous flaps used in orthopedic reconstructive surgery typically show increased signal intensity on T2-weighted images and contrast enhancement initially, followed by some degree of atrophy and increased signal intensity on T1-weighted images. Postoperative radiation therapy may increase the likelihood that the flap will exhibit increased T2-weighted signal and enhancement.

AB - OBJECTIVE. Our aim was to describe the MRI appearance of myocutaneous flaps and to determine whether postoperative radiation therapy affects imaging. MATERIALS AND METHODS. We retrospectively reviewed 30 myocutaneous flaps in 27 patients (n = 165 examinations; mean, 6.1 examinations per patient). Examinations were analyzed for flap type, location, degree of atrophy, signal intensity, and enhancement. RESULTS. Sixty-three percent (19/30) of the flaps developed high T1-weighted signal (mean, 15 months); 83% (25/30) developed high T2-weighted signal (mean, 10 months). This occurred sooner in those patients with postoperative radiation therapy (9 vs 12 months). T2-weighted signal returned to baseline in 32% (8/25) of the flaps (mean, 21 months); this occurred sooner in flaps not exposed to postoperative radiation (10 months vs 38 months). Seventy-one percent (20/28) of the flaps enhanced greater than the background musculature. Enhancement was seen more frequently in patients treated with postoperative radiation therapy than those not treated with radiation (83% vs 63%). All flaps atrophied; however, the two functional latissimus dorsi flaps atrophied less. Although increased T2-weighted signal and enhancement were seen in flaps after postoperative radiation therapy as compared with those without, this was not significant (p = 0.35 and p = 0.40, respectively). CONCLUSION. Myocutaneous flaps used in orthopedic reconstructive surgery typically show increased signal intensity on T2-weighted images and contrast enhancement initially, followed by some degree of atrophy and increased signal intensity on T1-weighted images. Postoperative radiation therapy may increase the likelihood that the flap will exhibit increased T2-weighted signal and enhancement.

KW - MRI

KW - Musculoskeletal imaging

KW - Myocutaneous flap

KW - Orthopedic surgery

KW - Radiation therapy

UR - http://www.scopus.com/inward/record.url?scp=33748476480&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748476480&partnerID=8YFLogxK

U2 - 10.2214/AJR.05.0484

DO - 10.2214/AJR.05.0484

M3 - Article

C2 - 16928948

AN - SCOPUS:33748476480

VL - 187

SP - 800

EP - 806

JO - American Journal of Roentgenology

JF - American Journal of Roentgenology

SN - 0361-803X

IS - 3

ER -